A study of muscarinic receptor heterogeneity with weak antagonists

Abraham Fisher, Yona Grunfeld, Marta Weinstock, Simon Gitter, Sasson Cohen*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

A study of heterogeneity among muscarinic receptors was carried out with new rigid molecules, comprising structures in the fused quinuclidine-valerolactone, quinuclidine-cyclohexenone, quinuclidine-cyclohexanone and quinuclidine-cyclohexane derivatives. These are structurally related to the potent muscarinic agent, 3-acetoxyquinuclidine but substantially different from it in conformation. All proved to antagonize acetylcholine-like activity, but to a different extent in different systems. The equipotent molar ratio with respect to atropine (as 1) was: isolated guinea pig ileum, 10,000-1,000; salivary gland (mouse), 1000-100; superior cervical ganglion (cat), 100-10; CNS (mouse), ∼10. It is suggested that the rigid structure induces a three-point constrained fit in the receptor (onium group, hydrophobic moiety and carbonyl group), but that not all muscarinic receptors are capable of responding equally. In this case, receptor specificity of the drug is a direct consequence of its graded departure from the preferred conformation of acetylcholine and, therefore, is necessarily associated with partial loss of potency.

Original languageEnglish
Pages (from-to)131-139
Number of pages9
JournalEuropean Journal of Pharmacology
Volume38
Issue number1
DOIs
StatePublished - Jul 1976
Externally publishedYes

Keywords

  • Quinuclidine-cyclohexane
  • Quinuclidine-cyclohexanone, fused
  • Quinuclidine-cyclohexenone
  • Quinuclidine-valerolactone, fused
  • Receptor-specific antagonists

Fingerprint

Dive into the research topics of 'A study of muscarinic receptor heterogeneity with weak antagonists'. Together they form a unique fingerprint.

Cite this